545 related articles for article (PubMed ID: 16764553)
1. Bioreactor systems for the production of biopharmaceuticals from animal cells.
Warnock JN; Al-Rubeai M
Biotechnol Appl Biochem; 2006 Jul; 45(Pt 1):1-12. PubMed ID: 16764553
[TBL] [Abstract][Full Text] [Related]
2. Conversion of a CHO cell culture process from perfusion to fed-batch technology without altering product quality.
Meuwly F; Weber U; Ziegler T; Gervais A; Mastrangeli R; Crisci C; Rossi M; Bernard A; von Stockar U; Kadouri A
J Biotechnol; 2006 May; 123(1):106-16. PubMed ID: 16324762
[TBL] [Abstract][Full Text] [Related]
3. Disposable bioreactors: the current state-of-the-art and recommended applications in biotechnology.
Eibl R; Kaiser S; Lombriser R; Eibl D
Appl Microbiol Biotechnol; 2010 Mar; 86(1):41-9. PubMed ID: 20094714
[TBL] [Abstract][Full Text] [Related]
4. Comparison of fluidized bed and ultrasonic cell-retention systems for high cell density mammalian cell culture.
Dürrschmid MP; Landauer K; Simic G; Klug H; Keijzer T; Trampler F; Oudshoorn A; Gröschl M; Müller D; Doblhoff-Dier O
Biotechnol Prog; 2003; 19(3):1045-8. PubMed ID: 12790677
[TBL] [Abstract][Full Text] [Related]
5. Production of a secreted glycoprotein from an inducible promoter system in a perfusion bioreactor.
Lipscomb ML; Mowry MC; Kompala DS
Biotechnol Prog; 2004; 20(5):1402-7. PubMed ID: 15458323
[TBL] [Abstract][Full Text] [Related]
6. Integrated continuous production of recombinant therapeutic proteins.
Warikoo V; Godawat R; Brower K; Jain S; Cummings D; Simons E; Johnson T; Walther J; Yu M; Wright B; McLarty J; Karey KP; Hwang C; Zhou W; Riske F; Konstantinov K
Biotechnol Bioeng; 2012 Dec; 109(12):3018-29. PubMed ID: 22729761
[TBL] [Abstract][Full Text] [Related]
7. Application of a cell-once-through perfusion strategy for production of recombinant antibody from rCHO cells in a Centritech Lab II centrifuge system.
Kim BJ; Chang HN; Oh DJ
Biotechnol Prog; 2007; 23(5):1186-97. PubMed ID: 17691812
[TBL] [Abstract][Full Text] [Related]
8. Scalable inoculation strategies for microcarrier-based animal cell bioprocesses.
Dürrschmid M; Landauer K; Simic G; Blüml G; Doblhoff-Dier O
Biotechnol Bioeng; 2003 Sep; 83(6):681-6. PubMed ID: 12889032
[TBL] [Abstract][Full Text] [Related]
9. Novel chemometric strategy based on the application of artificial neural networks to crossed mixture design for the improvement of recombinant protein production in continuous culture.
Didier C; Forno G; Etcheverrigaray M; Kratje R; Goicoechea H
Anal Chim Acta; 2009 Sep; 650(2):167-74. PubMed ID: 19720188
[TBL] [Abstract][Full Text] [Related]
10. An actively mixed mini-bioreactor for protein production from suspended animal cells.
Diao J; Young L; Zhou P; Shuler ML
Biotechnol Bioeng; 2008 May; 100(1):72-81. PubMed ID: 18078290
[TBL] [Abstract][Full Text] [Related]
11. Use of orbital shaken disposable bioreactors for mammalian cell cultures from the milliliter-scale to the 1,000-liter scale.
Zhang X; Stettler M; De Sanctis D; Perrone M; Parolini N; Discacciati M; De Jesus M; Hacker D; Quarteroni A; Wurm F
Adv Biochem Eng Biotechnol; 2009; 115():33-53. PubMed ID: 19499209
[TBL] [Abstract][Full Text] [Related]
12. Novel micro-bioreactor high throughput technology for cell culture process development: Reproducibility and scalability assessment of fed-batch CHO cultures.
Amanullah A; Otero JM; Mikola M; Hsu A; Zhang J; Aunins J; Schreyer HB; Hope JA; Russo AP
Biotechnol Bioeng; 2010 May; 106(1):57-67. PubMed ID: 20073088
[TBL] [Abstract][Full Text] [Related]
13. Animal cell cultures: recent achievements and perspectives in the production of biopharmaceuticals.
Butler M
Appl Microbiol Biotechnol; 2005 Aug; 68(3):283-91. PubMed ID: 15834715
[TBL] [Abstract][Full Text] [Related]
14. Continuous beer fermentation using immobilized yeast cell bioreactor systems.
Brányik T; Vicente AA; Dostálek P; Teixeira JA
Biotechnol Prog; 2005; 21(3):653-63. PubMed ID: 15932239
[TBL] [Abstract][Full Text] [Related]
15. Defining process design space for monoclonal antibody cell culture.
Abu-Absi SF; Yang L; Thompson P; Jiang C; Kandula S; Schilling B; Shukla AA
Biotechnol Bioeng; 2010 Aug; 106(6):894-905. PubMed ID: 20589669
[TBL] [Abstract][Full Text] [Related]
16. Improving performance of mammalian cells in fed-batch processes through "bioreactor evolution".
Prentice HL; Ehrenfels BN; Sisk WP
Biotechnol Prog; 2007; 23(2):458-64. PubMed ID: 17311405
[TBL] [Abstract][Full Text] [Related]
17. Scale-up of suspension and anchorage-dependent animal cells.
Griffiths B
Mol Biotechnol; 2001 Mar; 17(3):225-38. PubMed ID: 11434311
[TBL] [Abstract][Full Text] [Related]
18. An integrated process for mammalian cell perfusion cultivation and product purification using a dynamic filter.
Castilho LR; Anspach FB; Deckwer WD
Biotechnol Prog; 2002; 18(4):776-81. PubMed ID: 12153312
[TBL] [Abstract][Full Text] [Related]
19. Disposable bioreactors for inoculum production and protein expression.
Eibl R; Löffelholz C; Eibl D
Methods Mol Biol; 2014; 1104():265-84. PubMed ID: 24297422
[TBL] [Abstract][Full Text] [Related]
20. The status of membrane bioreactor technology.
Judd S
Trends Biotechnol; 2008 Feb; 26(2):109-16. PubMed ID: 18191260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
